We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01155583
Recruitment Status : Active, not recruiting
First Posted : July 2, 2010
Last Update Posted : June 12, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : May 28, 2016
  Estimated Study Completion Date : February 2018